Health Catalyst (HCAT) Competitors

MicroCloud Hologram (NASDAQ:HOLO) and Health Catalyst (NASDAQ:HCAT) are both small-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, community ranking, profitability, valuation, analyst recommendations, media sentiment, risk and earnings.

Does the media refer more to HOLO or HCAT?

In the previous week, Health Catalyst had 8 more articles in the media than MicroCloud Hologram. MarketBeat recorded 11 mentions for Health Catalyst and 3 mentions for MicroCloud Hologram. MicroCloud Hologram's average media sentiment score of 0.71 beat Health Catalyst's score of 0.45 indicating that MicroCloud Hologram is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MicroCloud Hologram	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Health Catalyst	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has better valuation and earnings, HOLO or HCAT?

MicroCloud Hologram has higher earnings, but lower revenue than Health Catalyst.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MicroCloud Hologram	$290.30M	0.05	-$11.55M	N/A	N/A
Health Catalyst	$306.58M	0.90	-$118.15M	-$1.15	-3.43

Do analysts rate HOLO or HCAT?

Health Catalyst has a consensus target price of $8.05, suggesting a potential upside of 103.68%. Given Health Catalyst's stronger consensus rating and higher possible upside, analysts plainly believe Health Catalyst is more favorable than MicroCloud Hologram.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MicroCloud Hologram	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Health Catalyst	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.70

Which has more volatility & risk, HOLO or HCAT?

MicroCloud Hologram has a beta of 3.67, meaning that its stock price is 267% more volatile than the S&P 500. Comparatively, Health Catalyst has a beta of 1.43, meaning that its stock price is 43% more volatile than the S&P 500.

Does the MarketBeat Community favor HOLO or HCAT?

Health Catalyst received 165 more outperform votes than MicroCloud Hologram when rated by MarketBeat users.

Company	Underperform	Outperform
MicroCloud Hologram	N/A	N/A
Health Catalyst	Outperform Votes 165 67.35%	Underperform Votes 80 32.65%

Do institutionals and insiders believe in HOLO or HCAT?

2.1% of MicroCloud Hologram shares are owned by institutional investors. Comparatively, 85.0% of Health Catalyst shares are owned by institutional investors. 2.5% of Health Catalyst shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Is HOLO or HCAT more profitable?

MicroCloud Hologram has a net margin of 0.00% compared to Health Catalyst's net margin of -26.20%. MicroCloud Hologram's return on equity of 0.00% beat Health Catalyst's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MicroCloud Hologram	N/A	N/A	N/A
Health Catalyst	-26.20%	-7.51%	-3.72%

Summary

Health Catalyst beats MicroCloud Hologram on 9 of the 15 factors compared between the two stocks.